Pierluigi Navarra
Affiliations: | catholic University Medical School, Washington, DC, United States |
Area:
NeuroendocrinologyGoogle:
"Pierluigi Navarra"Mean distance: 20.47 (cluster 31)
Children
Sign in to add trainee| Cinzia Dello Russo | grad student | 1997-2001 | catholic University Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dello Russo C, Di Franco V, Tabolacci E, et al. (2023) Remifentanil-induced hyperalgesia in healthy volunteers: a systematic review and meta-analysis of randomized controlled trials. Pain |
| Tringali G, Pizzoferrato M, Lisi L, et al. (2023) A Vicious NGF-p75 Positive Feedback Loop Exacerbates the Toxic Effects of Oxidative Damage in the Human Retinal Epithelial Cell Line ARPE-19. International Journal of Molecular Sciences. 24 |
| Lisi L, Pizzoferrato M, Ciotti GMP, et al. (2023) mTOR Inhibition Is Effective against Growth, Survival and Migration, but Not against Microglia Activation in Preclinical Glioma Models. International Journal of Molecular Sciences. 24 |
| Dello Russo C, Cappoli N, Tabolacci E, et al. (2023) Remifentanil does not affect human microglial immune activation in response to pro-inflammatory cytokines. Excli Journal. 22: 295-309 |
| Dello Russo C, Navarra P. (2023) What is the weight of expectation bias in oncology trials? British Journal of Clinical Pharmacology |
| De Pascale G, Pintaudi G, Lisi L, et al. (2023) Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible VAP: Clinical, Pharmacokinetic and Microbiome Features. Antibiotics (Basel, Switzerland). 12 |
| Lisi L, Marinelli S, Ciotti GMP, et al. (2022) The effects of painless nerve growth factor on human microglia polarization. Frontiers in Cellular Neuroscience. 16: 969058 |
| Dello Russo C, Navarra P. (2022) Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Uncontrolled Oncology Trials: A Comprehensive Review of the Literature. Frontiers in Pharmacology. 13: 858354 |
| Lisi L, Ciotti GMP, Chiavari M, et al. (2022) The effects of CHF6467, a new mutated form of NGF, on cell models of human glioblastoma. A comparison with wild-type NGF. Growth Factors (Chur, Switzerland). 1-9 |
| Graziani G, Lisi L, Tentori L, et al. (2022) Monoclonal Antibodies to CTLA-4 with Focus on Ipilimumab. Experientia Supplementum (2012). 113: 295-350 |